Cagrilintide Peptide research-grade
Cagrilintide Peptide
$69.00 $130.00Price range: $69.00 through $130.00 Select options

Cagrilintide Peptide

Price range: $69.00 through $130.00

Research-grade Cagrilintide Peptide for laboratory investigation. For Research Use Only. Not for human use.

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

Cagrilintide Peptide research-grade

Overview

Cagrilintide Peptide is supplied as a research-grade catalog material for controlled laboratory investigation.

Laboratories choose this item when protocols need clear identification, consistent labeling, and documentation suitable for reproducible experimental workflows.

Catalog packaging and research-use labeling help purchasing and bench teams keep procurement records aligned with the physical vial.

Research Context for Cagrilintide Peptide

Work involving Cagrilintide Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of Cagrilintide Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source Cagrilintide Peptide

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with Cagrilintide Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using Cagrilintide Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of Cagrilintide Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 34 PubMed records. Displaying 10 per page.

  1. Garvey WT et al. (2025). Laboratory research record on Cagrilintide [PMID: 40544433]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  2. Davies MJ et al. (2025). Laboratory research record on Cagrilintide [PMID: 40544432]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  3. Lau DCW et al. (2021). Laboratory research record on Cagrilintide [PMID: 34798060]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  4. Frias JP et al. (2023). Laboratory research record on Cagrilintide [PMID: 37364590]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  5. D'Ascanio AM et al. (2024). Cagrilintide: A Long-Acting Amylin Analog for the investigation of metabolic research… [PMID: 36883831]

    Laboratory literature summary: Cagrilintide: A Long-Acting Amylin Analog for the investigation of metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  6. Kruse T et al. (2021). Development of Cagrilintide, a Long-Acting Amylin Analogue [PMID: 34288673]

    Laboratory literature summary: Development of Cagrilintide, a Long-Acting Amylin Analogue. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  7. Dutta D et al. (2024). Observed endpoints and laboratory profile of Cagrilintide Alone and in Combination… [PMID: 39676787]

    Laboratory literature summary: observed endpoints and laboratory profile of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-metabolic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  8. Carvas AO et al. (2025). Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3 [PMID: 40609154]

    Laboratory literature summary: Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  9. Enebo LB et al. (2021). Laboratory research record on Cagrilintide [PMID: 33894838]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  10. Buse JB et al. (2026). Laboratory research record on Cagrilintide [PMID: 42251859]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  11. Rosenstock J et al. (2026). Laboratory research record on Cagrilintide [PMID: 42251856]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  12. Aroda VR et al. (2026). Laboratory research record on Cagrilintide [PMID: 42251860]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  13. Yamauchi T et al. (2026). Laboratory research record on Cagrilintide [PMID: 42009015]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  14. Chi H et al. (2025). Laboratory research record on Cagrilintide [PMID: 41259767]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  15. Cao J et al. (2025). Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors [PMID: 40204768]

    Laboratory literature summary: Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  16. Ludwig MQ et al. (2025). A Cross-Species Atlas of the Dorsal Vagal Complex Reveals Neural Mediators of… [PMID: 39868309]

    Laboratory literature summary: A Cross-Species Atlas of the Dorsal Vagal Complex Reveals Neural Mediators of Cagrilintide's Effects on Energy Balance. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  17. Ludwig MQ et al. (2026). A cross-species atlas of the dorsal vagal complex reveals neural mediators of the… [PMID: 42260119]

    Laboratory literature summary: A cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  18. Becerril S et al. (2021). Cagrilintide plus semaglutide for metabolic research models management [PMID: 33894837]

    Laboratory literature summary: Cagrilintide plus semaglutide for metabolic research models management. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  19. Gu YM et al. (2026). Structural and mechanistic insights into dual activation of cagrilintide in amylin and… [PMID: 40847076]

    Laboratory literature summary: Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  20. Gabery S et al. (2025). Characterization of 0839 – A tool compound for pre-laboratory mode-of-action studies… [PMID: 40628316]

    Laboratory literature summary: Characterization of 0839 – A tool compound for pre-laboratory mode-of-action studies of amylin analogues such as cagrilintide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  21. Gabe MBN et al. (2024). Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough… [PMID: 39279639]

    Laboratory literature summary: Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  22. Hamarsheh S et al. (2026). Laboratory research record on Cagrilintide [PMID: 42207966]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  23. Agarwal A et al. (2025). Laboratory research record on Cagrilintide [PMID: 41052437]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  24. Ahmed M et al. (2026). Observed endpoints and laboratory profile of Cagrilintide and Cagrisema Versus… [PMID: 41834765]

    Laboratory literature summary: observed endpoints and laboratory profile of Cagrilintide and Cagrisema Versus Semaglutide as Anti-metabolic research models…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  25. Krakauer JC et al. (2025). Laboratory research record on Cagrilintide [PMID: 41259765]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  26. Lnu V et al. (2025). Laboratory research record on Cagrilintide [PMID: 41259766]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  27. Fogacci F et al. (2025). Laboratory research record on Cagrilintide [PMID: 41259764]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  28. Hevesi Z et al. (2026). Cellular loci for cagrilintide action identified [PMID: 42260118]

    Laboratory literature summary: Cellular loci for cagrilintide action identified. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  29. Garvey WT et al. (2025). Laboratory research record on Cagrilintide [PMID: 41259768]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  30. Larsen AT et al. (2022). Does receptor balance matter? – Comparing the efficacies of the dual amylin and… [PMID: 36242844]

    Laboratory literature summary: Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  31. Davies MJ et al. (2025). Laboratory research record on Cagrilintide [PMID: 41259769]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  32. Rao H et al. (2026). Laboratory research record on Cagrilintide [PMID: 42180166]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  33. Scheen AJ (2026). Laboratory research record on Cagrilintide [PMID: 42251858]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

  34. Nielsen MJF et al. (2026). Laboratory research record on Cagrilintide [PMID: 42228334]

    PubMed laboratory record discussing Cagrilintide in a research context. Review the full methods and limitations on PubMed; research use only.

Browse the full PubMed index: PubMed search.

Additional information

Weight .125 lbs
Dimensions 9 × 7 × .5 in
Size: No selection

5mg, 10mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is Cagrilintide peptide?

Cagrilintide is a synthetic peptide analog of amylin. It is commonly studied in research laboratories for its interaction with metabolic and feeding-behavior endpoints-related biological pathways.

What is Cagrilintide used for in research?

Cagrilintide is used in research laboratories to investigate amylin receptor activity, metabolic signaling, and feeding-behavior endpoints-related mechanisms. It is not approved for human use.

Is Cagrilintide Peptide approved or intended for human use?

No. Cagrilintide is strictly intended for research purposes only and is not approved by the FDA for human use.

Is Cagrilintide Peptide FDA-approved for medical or clinical use?

No. Cagrilintide is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is Cagrilintide supplied?

Cagrilintide is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should Cagrilintide be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for Cagrilintide?

Cagrilintide is available in multiple vial sizes.

Is Cagrilintide Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is Cagrilintide shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments/

Is Cagrilintide studied in metabolic research models?

Cagrilintide is studied in research laboratories for metabolic and feeding-behavior endpoints-related pathways; however, it is not approved for the diagnosis, experimental regimen, cure, or prevention of any disease or condition.